Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Most Read

  1. New enzyme identified that cuts amino acid tyrosine off cytoskeleton
  2. AstraZeneca’s Faslodex with Verzenio receives FDA approval for advanced breast cancer
  3. FDA accepts for filing Alkermes’ NDA for schizophrenia treatment
  4. Redefinition of high blood pressure emphasises prevention
  5. Global Gene and OSUCCC-James to boost cancer research in South Asia

Latest Content

Micronova: Your Cleanroom’s Worth It

In today's world, the call for controlled manufacturing is standard across a wide range of industries. Processing and cleaning controls continue to grow ever more stringent in biotechnology and pharmaceutical production - at the same time engineers in wafer production and nanotechnology search for methods to attain higher yields.

ICER and NICE: are they that different?

The Institute for Clinical and Economic Review (ICER) is a non-profit organization in the US that aims to evaluate evidence of the value of medical tests, treatments and delivery system innovations that can be used to improve and inform the healthcare system.

Juno Therapeutics Explores CAR-T Trial Deaths

At the Society for Immunotherapy for Cancer (SITC) meeting in National Harbor, Maryland this weekend, Juno Therapeutics presented findings from their investigation into the circumstances surrounding the patient deaths linked to their former CAR-T pipeline candidate JCAR015.  Unusually, the deaths were all due to severe cerebral edema, which—unlike cytokine release syndrome—has generally not been a fatal side effect seen with other CAR-T therapies. Thus, the analysis of these specific patient deaths has been eagerly anticipated in hopes that these cases may inform future strategies for CAR-T therapy development.

Latest News

Read our magazine

Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.

Send me notifications of new editions:

Go Top